Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Revenue

Sansure Biotech had revenue of 418.05M CNY in the quarter ending September 30, 2026, with 11.33% growth. This brings the company's total for the last twelve months to 1.65B, down -1.19% year-over-year. In the year 2025, Sansure Biotech had annual revenue of 1.64B with 12.58% growth. That makes Sansure Biotech the 15,948th largest company in the world by revenue and 2,884th in China.

Revenue (ttm)
1.65B
Revenue Growth
-1.19%
P/S Ratio
5.08
Revenue / Employee
775.27K
Employees
2,064
Market Cap
8.39B

Revenue Chart

Revenue by Geography

  • China 1.53B 94.9%
  • Overseas 83.08M 5.1%
Fiscal year ended Dec 31, 2025 See the full Sansure Biotech breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.64B183.47M12.58%
Dec 31, 20241.46B450.94M44.78%
Dec 31, 20231.01B-5.44B-84.39%
Dec 31, 20226.45B1.94B42.88%
Dec 31, 20214.51B-248.42M-5.22%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.